Class II

Drug Recall: TIRZEPATIDE 60 mg/3mL (20/mg/mL), Rx Only, 3mL Multiple Dose Vial, Mfd by: ProRx Exton, PA, 19341, NDC 84139-210-02

ProRx LLC · August 22, 2024

Reason for Recall

Lack of Assurance of Sterility

Distribution

Nationwide in the USA

States Affected

NATIONWIDE

Quantity Affected

1,732 vials

Source: FDA (openFDA Drug Enforcement)

Recall number: D-0656-2024

Status: ongoing

SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.